Tags

Type your tag names separated by a space and hit enter

Late but not early gestational maternal growth hormone treatment increases fetal adiposity in overnourished adolescent sheep.
Biol Reprod 2006; 75(2):231-9BR

Abstract

In the overnourished adolescent sheep, maternal tissue synthesis is promoted at the expense of placental growth and leads to a major decrease in lamb birth weight at term. Maternal growth hormone (GH) concentrations are attenuated in these pregnancies, and it was recently demonstrated that exogenous GH administration throughout the period of placental proliferation stimulates uteroplacental and fetal development by Day 81 of gestation. The present study aimed to determine whether these effects persist to term and to establish whether GH affects fetal growth and body composition by increasing placental size or by altering maternal metabolism. Adolescent recipient ewes were implanted with singleton embryos on Day 4 postestrus. Three groups of ewes offered a high dietary intake were injected twice daily with recombinant bovine GH from Days 35 to 65 of gestation (high intake plus early GH) or from Days 95 to 125 of gestation (high intake plus late GH) or remained untreated (high intake only). A fourth moderate-intake group acted as optimally nourished controls. Pregnancies were terminated at Day 130 of gestation (6 per group) or were allowed to progress to term (8-10 per group). GH administration elevated maternal plasma concentrations of GH, insulin, glucose, and nonesterified fatty acids during the defined treatment windows, while urea concentrations were decreased. At Day 130, GH treatment had reduced the maternal adiposity score, percentage of fat in the carcass, and internal fat depots and leptin concentrations, predominantly in the high-intake plus late GH group. Placental weight was lower in high-intake vs. control dams but independent of GH treatment. In contrast, fetal weight was elevated by late GH treatment, and these fetuses had higher relative carcass fat content, perirenal fat mass, and liver glycogen concentrations than all other groups. Expression of leptin mRNA in fetal perirenal fat and fetal plasma leptin concentrations were not significantly altered by maternal nutritional intake or GH. In pregnancies proceeding to term, the duration of gestation, fetal placental mass, and lamb birth weight were reduced in high-intake compared with control dams but were not significantly affected by GH treatment. In conclusion, exogenous GH has profound effects on maternal endocrinology, metabolism, and body composition when administered during early and late pregnancy. Treatment during late pregnancy has a modest effect on fetal growth independent of placental size and a profound effect on fetal adiposity, which may have implications beyond the fetal period.

Authors+Show Affiliations

Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, United Kingdom. Jacqueline.Wallace@rri.sari.ac.ukNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16687645

Citation

Wallace, Jacqueline M., et al. "Late but Not Early Gestational Maternal Growth Hormone Treatment Increases Fetal Adiposity in Overnourished Adolescent Sheep." Biology of Reproduction, vol. 75, no. 2, 2006, pp. 231-9.
Wallace JM, Matsuzaki M, Milne J, et al. Late but not early gestational maternal growth hormone treatment increases fetal adiposity in overnourished adolescent sheep. Biol Reprod. 2006;75(2):231-9.
Wallace, J. M., Matsuzaki, M., Milne, J., & Aitken, R. (2006). Late but not early gestational maternal growth hormone treatment increases fetal adiposity in overnourished adolescent sheep. Biology of Reproduction, 75(2), pp. 231-9.
Wallace JM, et al. Late but Not Early Gestational Maternal Growth Hormone Treatment Increases Fetal Adiposity in Overnourished Adolescent Sheep. Biol Reprod. 2006;75(2):231-9. PubMed PMID: 16687645.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Late but not early gestational maternal growth hormone treatment increases fetal adiposity in overnourished adolescent sheep. AU - Wallace,Jacqueline M, AU - Matsuzaki,Masatoshi, AU - Milne,John, AU - Aitken,Raymond, Y1 - 2006/05/10/ PY - 2006/5/12/pubmed PY - 2006/12/9/medline PY - 2006/5/12/entrez SP - 231 EP - 9 JF - Biology of reproduction JO - Biol. Reprod. VL - 75 IS - 2 N2 - In the overnourished adolescent sheep, maternal tissue synthesis is promoted at the expense of placental growth and leads to a major decrease in lamb birth weight at term. Maternal growth hormone (GH) concentrations are attenuated in these pregnancies, and it was recently demonstrated that exogenous GH administration throughout the period of placental proliferation stimulates uteroplacental and fetal development by Day 81 of gestation. The present study aimed to determine whether these effects persist to term and to establish whether GH affects fetal growth and body composition by increasing placental size or by altering maternal metabolism. Adolescent recipient ewes were implanted with singleton embryos on Day 4 postestrus. Three groups of ewes offered a high dietary intake were injected twice daily with recombinant bovine GH from Days 35 to 65 of gestation (high intake plus early GH) or from Days 95 to 125 of gestation (high intake plus late GH) or remained untreated (high intake only). A fourth moderate-intake group acted as optimally nourished controls. Pregnancies were terminated at Day 130 of gestation (6 per group) or were allowed to progress to term (8-10 per group). GH administration elevated maternal plasma concentrations of GH, insulin, glucose, and nonesterified fatty acids during the defined treatment windows, while urea concentrations were decreased. At Day 130, GH treatment had reduced the maternal adiposity score, percentage of fat in the carcass, and internal fat depots and leptin concentrations, predominantly in the high-intake plus late GH group. Placental weight was lower in high-intake vs. control dams but independent of GH treatment. In contrast, fetal weight was elevated by late GH treatment, and these fetuses had higher relative carcass fat content, perirenal fat mass, and liver glycogen concentrations than all other groups. Expression of leptin mRNA in fetal perirenal fat and fetal plasma leptin concentrations were not significantly altered by maternal nutritional intake or GH. In pregnancies proceeding to term, the duration of gestation, fetal placental mass, and lamb birth weight were reduced in high-intake compared with control dams but were not significantly affected by GH treatment. In conclusion, exogenous GH has profound effects on maternal endocrinology, metabolism, and body composition when administered during early and late pregnancy. Treatment during late pregnancy has a modest effect on fetal growth independent of placental size and a profound effect on fetal adiposity, which may have implications beyond the fetal period. SN - 0006-3363 UR - https://www.unboundmedicine.com/medline/citation/16687645/Late_but_not_early_gestational_maternal_growth_hormone_treatment_increases_fetal_adiposity_in_overnourished_adolescent_sheep_ L2 - https://academic.oup.com/biolreprod/article-lookup/doi/10.1095/biolreprod.106.052605 DB - PRIME DP - Unbound Medicine ER -